• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK TARGET XL 360 SOFT 2MM X 6CM; DEVICE, NEUROVASCULAR EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK TARGET XL 360 SOFT 2MM X 6CM; DEVICE, NEUROVASCULAR EMBOLIZATION Back to Search Results
Catalog Number M0036122060
Medical Device Problem Code Expulsion (2933)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/10/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This is 2 of 2 reports.H3 other text : the subject device is unavailable to manufacturer.
 
Event or Problem Description
It was reported that during procedure after deployment of the subject coil device, the subject coil was protruding into the neck of the aneurysm as there was concern for compromise flow to the mca (middle cerebral artery) vasculature.Therefore, the stent was implanted to support the subject protruding coil and the medication was administered to the patient.The last visit was for the 12-month follow up, conducted on (b)(6) 2023, and the patient had mrs (modified rankin scale) and nihss (national institute of health stroke scale) score of 0.
 
Additional Manufacturer Narrative
D4 expiration date - added.H4 manufacturing date ¿ added.Due to the automated manufacturing execution system (mes) system there are controls in the manufacturing process to ensure the product met specifications upon release.The subject device was not available; therefore, a visual inspection as well as a functional evaluation could not be performed.The reported complaint could not be confirmed, and it could not be definitively determined if the device failed to meet specifications because the product was not returned.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.Based on the information provided the device was confirmed to be in good condition prior to use and there is no indication of any use issue.In the physicians opinion the device performed as intended.While there are a number of potential causes for the reported issue, because review and analysis of available information failed to identify a definitive cause and the device was not returned, an assignable cause of undeterminable was assigned.
 
Event or Problem Description
It was reported that during procedure after deployment of the subject coil device, the subject coil was protruding into the neck of the aneurysm as there was concern for compromise flow to the mca (middle cerebral artery) vasculature.Therefore, the stent was implanted to support the subject protruding coil and the medication was administered to the patient.The last visit was for the 12-month follow up, conducted on (b)(6) 2023, and the patient had mrs (modified rankin scale) and nihss (national institute of health stroke scale) score of 0.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TARGET XL 360 SOFT 2MM X 6CM
Common Device Name
DEVICE, NEUROVASCULAR EMBOLIZATION
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI  NA
Manufacturer (Section G)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI   NA
Manufacturer Contact
tara lopez
47900 bayside parkway
fremont, CA 94538
5104132500
MDR Report Key18668820
Report Number3008881809-2024-00052
Device Sequence Number7271308
Product Code HCG
UDI-Device Identifier07613327128260
UDI-Public07613327128260
Combination Product (Y/N)N
Initial Reporter StateKY
Initial Reporter CountryUS
PMA/510(K) Number
K153658
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 02/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/10/2025
Device Catalogue NumberM0036122060
Device Lot Number23414482
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 02/06/2024
Supplement Date Received by Manufacturer02/16/2024
Initial Report FDA Received Date02/08/2024
Supplement Report FDA Received Date02/19/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured01/12/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
AXS INFINITY (STRYKER); NEUROFORM ATLAS (STRYKER); SYNCHRO14 GUIDEWIRE (STRYKER)
Outcome Attributed to Adverse Event Required Intervention;
Patient Age69 YR
Patient SexMale
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-